compound introduction
Taprenepag isopropyl is a highly selective EP 2 receptor agonist. In Vivo Taprenepag isopropyl is a highly selective EP 2 receptor agonist. Intraocular pressure (IOP) in the left, vehicle-dosed eye typically remains within the normal range. In the right (Taprenepag isopropyl-dosed) eye, IOP is reduced in all dose groups. In the high-dose group, IOP is reduced to the extent that it cannot be measured ( IC50& Target:EP2
